Aida Pharmaceuticals (AIDA) Stock Overview

Engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. More details

AIDA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($8K)

Shares are highly illiquid

Latest financial reports are more than a year old

AIDA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Aida Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Aida Pharmaceuticals
Historical stock prices
Current Share Price	US$0.0003
52 Week High	US$0.0003
52 Week Low	US$0.0002
Beta	0
1 Month Change	50.50%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-98.96%
Change since IPO	-99.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AIDA	US Pharmaceuticals	US Market
7D	0%	1.6%	0.2%
1Y	n/a	30.7%	18.7%

Return vs Industry: Insufficient data to determine how AIDA performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how AIDA performed against the US Market.

Price Volatility

Is AIDA's price volatile compared to industry and market?
AIDA volatility
AIDA Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.0%
Market Average Movement	6.5%
10% most volatile stocks in US Market	16.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: AIDA's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine AIDA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1999	n/a	Biao Jin	n/a

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.

Aida Pharmaceuticals, Inc. Fundamentals Summary

How do Aida Pharmaceuticals's earnings and revenue compare to its market cap?
AIDA fundamental statistics
Market cap	US$8.13k
Earnings (TTM)	-US$2.18m
Revenue (TTM)	US$40.51m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is AIDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AIDA income statement (TTM)
Revenue	US$40.51m
Cost of Revenue	US$18.20m
Gross Profit	US$22.30m
Other Expenses	US$24.48m
Earnings	-US$2.18m

Last Reported Earnings

Sep 30, 2008

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AIDA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/14 12:44
End of Day Share Price	2025/12/30 00:00
Earnings	2008/09/30
Annual Earnings	2007/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aida Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.